CMRX
Chimerix (CMRX)
$88
About Chimerix (CMRX)
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Details
Daily high
$0.89
Daily low
$0.87
Price at open
$0.87
52 Week High
$1.30
52 Week Low
$0.75
Market cap
78.3M
Dividend yield
0.00%
Volume
53,216
Avg. volume
162,114
P/E ratio
-.92
Chimerix News
Details
Daily high
$0.89
Daily low
$0.87
Price at open
$0.87
52 Week High
$1.30
52 Week Low
$0.75
Market cap
78.3M
Dividend yield
0.00%
Volume
53,216
Avg. volume
162,114
P/E ratio
-.92